CY2367B1 - Swallow tablet comprising paracetamol. - Google Patents

Swallow tablet comprising paracetamol.

Info

Publication number
CY2367B1
CY2367B1 CY0300050A CY0300050A CY2367B1 CY 2367 B1 CY2367 B1 CY 2367B1 CY 0300050 A CY0300050 A CY 0300050A CY 0300050 A CY0300050 A CY 0300050A CY 2367 B1 CY2367 B1 CY 2367B1
Authority
CY
Cyprus
Prior art keywords
paracetamol
swallow tablet
swallow
tablet
Prior art date
Application number
CY0300050A
Other languages
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CY2367B1 publication Critical patent/CY2367B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
CY0300050A 1997-03-05 2003-07-15 Swallow tablet comprising paracetamol. CY2367B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition

Publications (1)

Publication Number Publication Date
CY2367B1 true CY2367B1 (en) 2004-06-04

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300050A CY2367B1 (en) 1997-03-05 2003-07-15 Swallow tablet comprising paracetamol.

Country Status (36)

Country Link
US (1) US6316025B1 (fr)
EP (1) EP0981334B1 (fr)
JP (1) JP2001513801A (fr)
KR (1) KR100465895B1 (fr)
CN (1) CN100389751C (fr)
AP (1) AP1084A (fr)
AR (1) AR011919A1 (fr)
AT (1) ATE240720T1 (fr)
AU (1) AU721851B2 (fr)
BG (1) BG64348B1 (fr)
BR (1) BR9807992A (fr)
CA (1) CA2283408C (fr)
CO (1) CO4940406A1 (fr)
CY (1) CY2367B1 (fr)
CZ (1) CZ294078B6 (fr)
DE (1) DE69814850T2 (fr)
DK (1) DK0981334T3 (fr)
EA (1) EA001918B1 (fr)
ES (1) ES2199435T3 (fr)
GB (1) GB9704524D0 (fr)
HK (1) HK1027026A1 (fr)
HU (1) HU224983B1 (fr)
ID (1) ID22233A (fr)
IL (1) IL131552A (fr)
MY (1) MY119722A (fr)
NO (1) NO327456B1 (fr)
NZ (1) NZ337418A (fr)
PE (1) PE68899A1 (fr)
PL (1) PL190988B1 (fr)
PT (1) PT981334E (fr)
SK (1) SK282277B6 (fr)
TR (1) TR199902175T2 (fr)
TW (1) TW508242B (fr)
UA (1) UA59388C2 (fr)
WO (1) WO1998038983A2 (fr)
ZA (1) ZA981832B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
BRPI0409127A (pt) * 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2566331C (fr) * 2004-05-28 2011-03-15 Imaginot Pty Ltd. Systeme d'administration par voie orale
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
BRPI0520000A2 (pt) * 2004-10-28 2009-04-07 Novartis Ag composição compreendendo acetaminofeno, cafeìna e opcionalmente aspirina juntos com um agente alcalino para absorção intensificada
WO2006138278A1 (fr) * 2005-06-13 2006-12-28 Paul Rosenberg Capsule contenant un émétique
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
EP3449928A1 (fr) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Système d'administration d'un composé thérapeutique oral
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
EP2043613A1 (fr) * 2006-07-14 2009-04-08 Fmc Corporation Forme solide
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
EP2203165B1 (fr) * 2007-08-07 2013-05-22 Stellenbosch University Paracetamol pour l'utilisation dans le traitement du glaucome
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
CA3115122A1 (fr) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Formulations de medicament resistant a l'alcool

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (fr) 1981-07-13 1985-02-05 Francis J. Sterbenz Compose d'apap et d'antiacide
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (fr) 1989-09-01 1991-03-02 Ronald Nash Duvall Compose medicinal effervescent a teneur reduite en sodium pour le soulagement des symptomes du rhume et des allergies
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
CN1253497A (zh) 2000-05-17
ID22233A (id) 1999-09-23
EA199900709A1 (ru) 2000-08-28
CN100389751C (zh) 2008-05-28
ES2199435T3 (es) 2004-02-16
ATE240720T1 (de) 2003-06-15
EP0981334A1 (fr) 2000-03-01
CZ314899A3 (cs) 2000-03-15
SK282277B6 (sk) 2002-01-07
CA2283408A1 (fr) 1998-09-11
EP0981334B1 (fr) 2003-05-21
NO994294L (no) 1999-09-03
US6316025B1 (en) 2001-11-13
CZ294078B6 (cs) 2004-09-15
BR9807992A (pt) 2000-03-08
AU721851B2 (en) 2000-07-13
GB9704524D0 (en) 1997-04-23
TR199902175T2 (xx) 1999-12-21
KR100465895B1 (ko) 2005-01-13
PL190988B1 (pl) 2006-02-28
CO4940406A1 (es) 2000-07-24
JP2001513801A (ja) 2001-09-04
AP1084A (en) 2002-07-23
BG103714A (en) 2000-05-31
SK119799A3 (en) 2000-02-14
NO327456B1 (no) 2009-07-06
KR20000075897A (ko) 2000-12-26
EA001918B1 (ru) 2001-10-22
DK0981334T3 (da) 2003-09-22
MY119722A (en) 2005-07-29
DE69814850D1 (de) 2003-06-26
WO1998038983A2 (fr) 1998-09-11
AP9901638A0 (en) 1999-09-30
AR011919A1 (es) 2000-09-13
TW508242B (en) 2002-11-01
CA2283408C (fr) 2007-01-02
IL131552A0 (en) 2001-01-28
IL131552A (en) 2004-08-31
DE69814850T2 (de) 2004-03-11
NZ337418A (en) 2000-05-26
PL335502A1 (en) 2000-04-25
HU224983B1 (en) 2006-05-29
HUP0001501A2 (hu) 2000-09-28
WO1998038983A3 (fr) 1998-12-17
HK1027026A1 (en) 2001-01-05
AU6828298A (en) 1998-09-22
ZA981832B (en) 1998-12-11
BG64348B1 (bg) 2004-11-30
PE68899A1 (es) 1999-09-26
HUP0001501A3 (en) 2001-01-29
NO994294D0 (no) 1999-09-03
UA59388C2 (uk) 2003-09-15
PT981334E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
CY2367B1 (en) Swallow tablet comprising paracetamol.
ZA989061B (en) Medicaments.
MXPA02000992A (es) Microarreglos y su fabricacion.
ZA993338B (en) Pharmaceutical formulations.
ZA200101762B (en) Immediate release tablet.
HK1036230A1 (en) Drug delivery devices.
HK1027957A1 (en) Pharmaceutical composition.
ZA981029B (en) Pharmaceutical agents.
ZA9811504B (en) Novel pharmaceutical.
ZA9811506B (en) Novel pharmaceutical.
ZA200203707B (en) Pharmaceutical combinations.
EP1145714A4 (fr) Medicaments
ZA9811505B (en) Novel pharmaceutical.
ZA991212B (en) Pharmaceutical combinations comprising tramadol.
PL367985A1 (en) Swallow tablet comprising paracetamol
ZA987392B (en) Pharmaceutical composition.
AU141186S (en) Tablet
HK1040488A1 (en) Pharmaceutical formulations.
GB9826000D0 (en) Tablets
ZA200110454B (en) Pharmaceutical complex.
ZA982558B (en) Novel Pharmaceutical.
SI0981334T1 (en) Swallow tablet comprising paracetamol
ZA994697B (en) Pharmaceutical formulation.
ZA99918B (en) Pharmaceutical formulation.
CA83558S (en) Pharmaceutical tablet